BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 23, 2003
View Archived Issues
Benzimidazole CDK4 inhibitors under study at Aventis
Read More
Merck scientists present a novel GABA-A agonist for use in anxiety and convulsions
Read More
Fuji Photo Film claims new contrast agents for the diagnosis of vascular disorders
Read More
New HIV protease inhibitors in early development at BMS
Read More
Pfizer patent covers novel thyroid receptor ligands and their use
Read More
Dithiazole-based MMP inhibitors newly discovered at Shiseido
Read More
Vitamin E analogue sensitizes Jurkat cells by suppressing NF-kB activation
Read More
Restructuring update at CeNeS
Read More
Arava approved for rheumatoid arthritis in Japan
Read More
Ketek may exacerbate symptoms of myasthenia gravis
Read More
Vilazodone results fail to support progression to phase III
Read More
Northwest Biotherapeutics receives NCI grant for tumor growth inhibition
Read More
Nastech reacquires intranasal apomorphine rights following Pfizer-Pharmacia merger
Read More
DynPort completes smallpox vaccine phase I trial
Read More
Patient treatment begins in phase I trial of VIT-100
Read More
Phase II studies of ILX-651 planned
Read More
Virulizin phase III trial extended to Canada and Mexico
Read More
Ribozyme changes name
Read More
AGI Dermatics regains rights to Dimericine
Read More
Novo Nordisk and Fournier sign repaglinide comarketing deal for Europe
Read More
Vasopeptidase inhibitor as effective as ACE inhibitor in old SHR
Read More
Tricyclic bis-enone compounds as inhibitors of NO production
Read More
Profile of SLV-310, a potential antipsychotic agent
Read More
5-HT6 receptor-selective antagonist reverses cognitive deficits in animal model
Read More
